Exlites Holdings International (EXHI) Stock Price, News & Analysis

Company Overview

Exlites Holdings International, Inc. manufactures and distributes medical products. The company distributes and manufactures therapeutic pain, exercise, weight loss, and DVT prevention systems for use by patients. It sells proprietary patented and patent pending health care products, such as deep vein thrombosis units, transcutaneous electrical nerve stimulation units, electronic muscle stimulation units, various bracing products, and other medical and consumer healthcare products. The company also focuses on electric vehicle range extenders. The company was founded in 1979 and is headquartered in Tampa, Florida.

Key Stats

• Today's Range: $0.30 to $0.30
• 50-Day Range: $0.30 to $0.30
• 52-Week Range: $0.18 to $3.80
• Volume: 1 shs
• Average Volume: 1 shs
• Market Capitalization: $13.30 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

EXHI Stock Analysis - Frequently Asked Questions

How have EXHI shares performed this year?

Exlites Holdings International's stock was trading at $0.2725 at the beginning of the year. Since then, EXHI stock has increased by 10.9% and is now trading at $0.3021.
View the best growth stocks for 2024 here.

How do I buy shares of Exlites Holdings International?

Shares of EXHI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Company Calendar

• Today: 11/19/2024
• Fiscal Year End: 1/31/2025

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Consumer Staples
• Industry: Telephone & telegraph apparatus
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:EXHI
• CUSIP: N/A
• CIK: N/A
• Web: exlitesholdings.com
• Phone: (813) 321-9551
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 44,040,000
• Free Float: 35,706,000
• Market Cap: $13.30 million
• Optionable: Not Optionable
• Beta: -2.07